Literature DB >> 11456026

Sympathetic ophthalmia after complicated cataract surgery and intraocular lens implantation.

A M El-Asrar1, S A Al-Obeidan.   

Abstract

PURPOSE: To report a case of sympathetic ophthalmia (SO) associated with cataract surgery and intraocular lens (IOL) implantation.
METHODS: Case report.
RESULTS: A 50-year-old man developed SO two months after complicated cataract surgery and IOL implantation. Adequate and prompt use of immunosuppressive medications and removal of the IOL by pars plana vitrectomy techniques resulted in control of the uveitis with significant visual improvement.
CONCLUSIONS: Sympathetic ophthalmia should be included as one of the devastating complications of IOL insertion. A high index of suspicion must be maintained whenever inflammation occurs in the fellow eye of an eye that has undergone intraocular surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456026     DOI: 10.1177/112067210101100218

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  5 in total

1.  Sympathetic ophthalmia after ruthenium plaque brachytherapy.

Authors:  Nadeem Ahmad; Terrence K Soong; Sachin Salvi; Paul A Rudle; Ian G Rennie
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

Review 2.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

3.  Sympathetic Ophthalmia Two Weeks After 23-Gauge Vitrectomy.

Authors:  Bahaeddin B E El Khatib; Menka S M P Patel; Alexander A H Hacopian; Monica M D Dalal; H Nida H N S Sen; Marena M P Patronas
Journal:  J Ophthalmic Inflamm Infect       Date:  2020-06-26

4.  Sympathetic ophthalmia: to the twenty-first century and beyond.

Authors:  Xi K Chu; Chi-Chao Chan
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-06-01

Review 5.  Gender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia.

Authors:  Yujuan Wang; Chi-Chao Chan
Journal:  J Ophthalmol       Date:  2014-03-05       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.